Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
Abstract Background Asthma is a chronic disease characterized by airway hyperresponsiveness, inflammation and mucus production. In Type 2 asthma, two phenotypic components are often co-expressed (eosinophilic and allergic). Elevated biomarker levels, such as eosinophils (EOS), fraction of exhaled ni...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-05-01
|
| Series: | Clinical and Molecular Allergy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12948-021-00146-9 |